![Tibor Keler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tibor Keler
Gründer bei
CELLDEX THERAPEUTICS, INC.
Vermögen: 231 231 $ am 31.05.2026
Profil
Tibor Keler is the founder of Celldex Therapeutics, Inc., founded in 1983, holding the title of Chief Scientific Officer & Executive VP.
The current job is Chief Scientific Officer, VP-Research & Discovery at Celldex Research Corp.
since 2003.
Former jobs include Senior Director-Preclinical Development at Medarex, Inc. from 2003 to 2004, Chief Scientific Officer & Senior Vice President at AVANT Immunotherapeutics, Inc. in 2008, and Chief Scientific Officer, VP-Research & Discovery at Celldex Therapeutics, Inc. (Old) from 2003 to 2008.
Education includes a doctorate from the University of Pennsylvania and undergraduate and graduate degrees from Drexel University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 7.357 ( 0,01 % ) | 231 231 $ | 31.05.2026 |
Aktive Positionen von Tibor Keler
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Gründer | 01.01.1983 |
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2003 |
Ehemalige bekannte Positionen von Tibor Keler
| Unternehmen | Position | Ende |
|---|---|---|
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2008 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2008 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Corporate Officer/Principal | 01.03.2004 |
Ausbildung von Tibor Keler
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
42
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Celldex Therapeutics, Inc. (Old)
Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Commercial Services |
